Streetbeat News

Products Services

VERA

Vera Therapeutics has initiated a pivotal Phase 3 clinical trial of Atacicept for the treatment of IgA Nephropathy, a rare kidney disease with limited treatment options.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 12:03 pm

CRM

GOOG

GOOGL

Salesforce and Google Cloud announced an integration between Salesforce Data Cloud and Google Cloud's Vertex AI, allowing users to bring their own AI models for enhanced data analysis.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 12:02 pm

SBUX

Starbucks plans to attract value-conscious customers in India by offering smaller, cheaper beverages and expanding into smaller towns. The company faces competition from local chains Third Wave and Blue Tokai, which have grown rapidly in recent years.

Portfolio Pulse from Anusuya Lahiri

June 07, 2023 | 11:52 am

META

SNAP

Meta Platforms is testing a new AI chatbot feature on Instagram, enabling users to chat with an AI chatbot in their direct messages. The chatbot is similar to Snapchat's My AI, which failed to gain traction. Meta has also been incorporating generative AI technology into various features across its platforms, including ads.

Portfolio Pulse from Anusuya Lahiri

June 07, 2023 | 11:36 am

ALGS

Aligos Therapeutics will present data on its liver disease programs at the European Association for the Study of the Liver (EASL) Congress 2023 from June 21-24.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:31 am

ICPT

Intercept Pharmaceuticals announced new data showing the potential of a fixed-dose combination of Obeticholic Acid and Bezafibrate to normalize multiple biomarkers in Primary Biliary Cholangitis.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:20 am

ORGS

Orgenesis has announced a partnership agreement with the University of California system to roll out its Mobile Processing Units and Labs (OMPULs) at medical or academic institutions. This will enable Orgenesis' proprietary point-of-care (POCare) Service Platform to manufacture therapeutics at hospitals throughout California for clinical trials.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:12 am

TNXP

Tonix Pharmaceuticals announced data presentations involving TNX-1500 for the prevention of rejection in kidney and heart allograft transplantation in animal models. TNX-1500 is expected to enter Phase 1 trial in Q3 2023.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:09 am

VTYX

Ventyx Biosciences has completed enrollment for its Phase 2 trials of VTX002 in ulcerative colitis and VTX958 in plaque psoriasis. Topline data for both trials are expected in early Q4 and Q4 2023, respectively.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:06 am

PCRFY

PLTR

Panasonic Energy of North America (PENA) has chosen Palantir Foundry to operationalize data and introduce automated efficiencies in its operations. This partnership aims to improve PENA's manufacturing processes and reduce costs.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:04 am